Effects of maternal Mediterranean diet on fetal cardiac function in high-risk pregnancies: a secondary analysis of the IMPACT BCN randomized trial.
Por:
Youssef L, Araujo K, Testa L, Novoa RH, Borras R, Castro-Barquero S, Bernardino G, Bijnens B, Crovetto F, Gratacos E and Crispi F
Publicada:
1 feb 2026
Ahead of Print:
17 dic 2025
Resumen:
BACKGROUND: Maternal suboptimal nutrition and high stress levels are associated with altered fetal cardiovascular function. OBJECTIVE: This study aimed to assess the effect of structured maternal lifestyle interventions based on a Mediterranean diet or mindfulness-based stress reduction during pregnancy on fetal cardiac function. STUDY DESIGN: This was a secondary analysis of the IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa) randomized clinical trial, which was conducted at a university hospital in Barcelona, Spain, from February 2017 to March 2020. A total of 1221 singleton pregnancies (19-23 weeks' gestation) with high risk of delivering small-for-gestational-age newborns were randomly allocated into 3 groups in a 1:1:1 ratio: a Mediterranean diet intervention, a stress reduction program, or usual care. Participants in the Mediterranean diet group received monthly individual and group educational sessions and free provision of extra-virgin olive oil and walnuts. Those in the stress reduction group underwent an 8-week mindfulness-based stress reduction program adapted for pregnancy. Individuals in the usual care group received pregnancy care per institutional protocols. Fetal cardiac function was assessed using cord blood NT-proBNP (N-terminal probrain natriuretic peptide) and fetal echocardiography. NT-proBNP was measured in cord blood collected at delivery and considered high if >90(th) centile. Fetal echocardiography was performed at 33 to 34 weeks' gestation. Data were analyzed from January to July 2024. RESULTS: Fetal echocardiography and cord blood NT-proBNP measurements were obtained in 990 and 746 pregnancies, respectively. Whereas fetuses in the stress reduction group showed similar fetal cardiac results, the proportion of fetuses with high cord blood NT-proBNP concentrations was significantly lower in the Mediterranean diet group (6.4% vs 12%; P=.03) compared with the usual care group. Additionally, fetuses whose mothers followed the Mediterranean diet exhibited higher right ventricular fractional area change (mean [standard deviation], 30.4% [8.3] vs 28.1% [8.9]; P=.03) and thinner myocardial walls (mean [standard deviation], 2.95 [0.55] vs 3.16 [0.58] mm; P=.006) compared with the usual care group. CONCLUSION: Promotion of a maternal Mediterranean diet intervention during pregnancy seems to be associated with a less overloaded and more efficient fetal heart. Future research is warranted to elucidate the mechanism(s) underlying these findings.
Filiaciones:
:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Josep Carreras Leukaemia Research Institute, Clínic Campus, Barcelona, Spain (Youssef)
Araujo K:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Departamento de Obstetricia, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile (Araujo)
Testa L:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Novoa RH:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Borras R:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Cardiovascular Institute, Hospital Clínic, IDIBAPS, Universitat Autònoma de Barcelona, Barcelona, Spain (Borras)
CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental), Instituto de Salud Carlos III, Madrid, Spain (Borras)
Castro-Barquero S:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Institut de Recerca en Nutrició i Seguretat Alimentària (INSA-UB), University of Barcelona, Barcelona, Spain (Castro-Barquero)
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA (Castro-Barquero)
Bernardino G:
BCN MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain (Bernardino and Bijnens)
Bijnens B:
BCN MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain (Bernardino and Bijnens)
ICREA (Institució Catalana de Recerca i Estudis Avançats), Barcelona, Spain (Bijnens)
Crovetto F:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
Institut de Recerca Sant Joan de Déu, Barcelona, Spain (Crovetto)
RICORS-SAMID (Primary care interventions to prevent maternal and child chronic diseases of perinatal and developmental origin RD21/0012/0003) Network, Instituto de Salud Carlos III, Madrid, Spain (Crovetto)
Gratacos E:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
CIBERER (Centre for Biomedical Research on Rare Diseases), Madrid, Spain (Gratacos and Crispi)
Crispi F:
BCNatal (Hospital Clínic and Hospital Sant Joan de Déu), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain (Youssef, Araujo, Testa, Novoa, Borras, Castro-Barquero, Crovetto, Gratacos, and Crispi)
CIBERER (Centre for Biomedical Research on Rare Diseases), Madrid, Spain (Gratacos and Crispi)
|